Sections

Lists

emcure pharmaceuticals

Insta-Subscribe to Forbes India Magazine

For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you

OR

click here to Subscribe Online

Popular Now

Is study abroad turning burden from boon?
Why Adidas is betting big on Indian cricket
Zomato's Blinkit has a great durable competitive advantage over Flipkart: Sanjeev Bikhchandani and Deepinder Goyal
China and the US reshaping their semiconductor supply chains present both challenges and opportunities for India: Chris Miller
How Mokobara shed its baggage
The global race for AI chips intensifies. Where does India stand?
Novartis: Innovating for the world, from India
Inside Vasant 'Vas' Narasimhan's transformation of Novartis, and more
India has what it takes to become a global semiconductor powerhouse: Qualcomm's Rahul Patel
$1 trillion market cap not just a possibility but a vision for future of startups: Redseer Strategy

Tweets by @forbesindia

How Australia, Ireland and South Korea are gaining popularity for overseas education
Hong Kong grants approval for first Bitcoin ETFs
Photo of the day: Under attack
With a record $776.68 billion worth of exports in FY24, India's trade deficit narrows to $78 billion
Vodafone Idea FPO: Is Rs 18,000 crore enough to save a wreckage?
Record cocoa prices and its bitter aftertaste

CONTACT US ADVERTISE WITH US SUBSCRIBE FORBES INDIA MARQUEE LEADERSHIP AWARDS

PRIVACY POLICY COOKIE POLICY TERMS & CONDITIONS DISCLAIMER